Literature DB >> 15067072

Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway.

Sathit Pichyangkul1, Kosol Yongvanitchit, Utaiwan Kum-arb, Hiroaki Hemmi, Shizuo Akira, Arthur M Krieg, D Gray Heppner, V Ann Stewart, Hitoshi Hasegawa, Sornchai Looareesuwan, G Dennis Shanks, R Scott Miller.   

Abstract

A common feature of severe Plasmodium falciparum infection is the increased systemic release of proinflammatory cytokines that contributes to the pathogenesis of malaria. Using human blood, we found that blood stage schizonts or soluble schizont extracts activated plasmacytoid dendritic cells (PDCs) to up-regulate CD86 expression and produce IFN-alpha. IFN-alpha production was also detected in malaria-infected patients, but the levels of circulating PDCs were markedly reduced, possibly because of schizont-stimulated up-regulation of CCR7, which is critical for PDC migration. The schizont-stimulated PDCs elicited a poor T cell response, but promoted gamma delta T cell proliferation and IFN-gamma production. The schizont immune stimulatory effects could be reproduced using murine DCs and required the Toll-like receptor 9 (TLR9)-MyD88 signaling pathway. Although the only known TLR9 ligand is CpG motifs in pathogen DNA, the activity of the soluble schizont extract was far greater than that of schizont DNA, and it was heat labile and precipitable with ammonium sulfate, unlike the activity of bacterial DNA. These results demonstrate that schizont extracts contain a novel and previously unknown ligand for TLR9 and suggest that the stimulatory effects of this ligand on PDCs may play a key role in immunoregulation and immunopathogenesis of human falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067072     DOI: 10.4049/jimmunol.172.8.4926

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  110 in total

1.  Integrated immune responses to infection - cross-talk between human gammadelta T cells and dendritic cells.

Authors:  Matthias Eberl; Hassan Jomaa; Adrian C Hayday
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

2.  Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2.

Authors:  Abdul Q Khan; Quanyi Chen; Zheng-Qi Wu; James C Paton; Clifford M Snapper
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 3.  Plasmacytoid dendritic cells: linking innate and adaptive immunity.

Authors:  Kelli McKenna; Anne-Sophie Beignon; Nina Bhardwaj
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria.

Authors:  Frank P Mockenhaupt; Jakob P Cramer; Lutz Hamann; Miriam S Stegemann; Jana Eckert; Na-Ri Oh; Rowland N Otchwemah; Ekkehart Dietz; Stephan Ehrhardt; Nicolas W J Schröder; Ulrich Bienzle; Ralf R Schumann
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

5.  Cyclic GMP-AMP Synthase Is the Cytosolic Sensor of Plasmodium falciparum Genomic DNA and Activates Type I IFN in Malaria.

Authors:  Carolina Gallego-Marin; Jacob E Schrum; Warrison A Andrade; Scott A Shaffer; Lina F Giraldo; Alvaro M Lasso; Evelyn A Kurt-Jones; Katherine A Fitzgerald; Douglas T Golenbock
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

6.  Toll-like receptor 7 mediates early innate immune responses to malaria.

Authors:  Alyssa Baccarella; Mary F Fontana; Eunice C Chen; Charles C Kim
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

7.  Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1.

Authors:  Salenna R Elliott; Timothy P Spurck; Joelle M Dodin; Alexander G Maier; Till S Voss; Francisca Yosaatmadja; Paul D Payne; Geoffrey I McFadden; Alan F Cowman; Stephen J Rogerson; Louis Schofield; Graham V Brown
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

8.  Baculovirus-based nasal drop vaccine confers complete protection against malaria by natural boosting of vaccine-induced antibodies in mice.

Authors:  Shigeto Yoshida; Hitomi Araki; Takashi Yokomine
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

9.  Hemozoin from Schistosoma japonicum does not affect murine myeloid dendritic cell function.

Authors:  Yanyan Jiang; Xiangyang Xue; Xiaoping Chen; Wenjia Zhuang; Jun Sun; Li Shen; Weiqing Pan
Journal:  Parasitol Res       Date:  2010-01-20       Impact factor: 2.289

Review 10.  Effects of type I interferons in malaria.

Authors:  Ismail Sebina; Ashraful Haque
Journal:  Immunology       Date:  2018-07-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.